Black Friday saleUp to 70% OFF
Merck & Co. Inc.Merck & Co. Inc.Merck & Co. Inc.

Merck & Co. Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

6MK chart


Full chart

6MK upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪243.88 B‬ EUR
Dividend yield (indicated)
3.20%
Price to earnings Ratio (TTM)
21.12
Basic EPS (TTM)
4.31 EUR
Net income (FY)
‪330.69 M‬ EUR
Revenue (FY)
‪54.24 B‬ EUR
Shares float
‪2.53 B‬
Beta (1Y)
0.61

Employees


Employees (FY)
‪72 K‬
Change (1Y)
‪+3 K‬ +4.35%
Revenue / Employee (1Y)
‪831.54 K‬ EUR
Net income / Employee (1Y)
‪5.07 K‬ EUR

About Merck & Company, Inc.


Sector
Health Technology
CEO
Robert M. Davis
Headquarters
Rahway
Website
merck.com
Founded
1891
FIGI
BBG000G583J5
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

6MK news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

6MK highest yielding bonds


MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050
Yield to maturity
6.59%
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061
Yield to maturity
6.58%
Maturity date
Dec 10, 2061
US58933YBF1
MERCK & CO. 21/51
Yield to maturity
6.50%
Maturity date
Dec 10, 2051
US58933YBA2
MERCK & CO. 20/40
Yield to maturity
6.25%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045
Yield to maturity
5.93%
Maturity date
Feb 10, 2045
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042
Yield to maturity
5.83%
Maturity date
Sep 15, 2042
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049
Yield to maturity
5.81%
Maturity date
Mar 7, 2049
MRK.GF
Merck & Co., Inc. 5.76% 03-MAY-2037
Yield to maturity
5.70%
Maturity date
May 3, 2037
US58933YAJ4
MERCK CO. 13/43
Yield to maturity
5.66%
Maturity date
May 18, 2043
US58933YAV7
MERCK & CO. 19/39
Yield to maturity
5.57%
Maturity date
Mar 7, 2039
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063
Yield to maturity
5.48%
Maturity date
May 17, 2063

Explore more bonds 

Sparks


Curated watchlists where 6MK is featured.

See all sparks 

Frequently Asked Questions


The current price of 6MK is 96.80 EUR — it has increased by 0.52% in the past 24 hours. Watch Merck & Co. Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Merck & Co. Inc. stocks are traded under the ticker 6MK.
6MK stock has risen by 6.15% compared to the previous week, the month change is a −1.02% fall, over the last year Merck & Co. Inc. has showed a 4.65% increase.
We've gathered analysts' opinions on Merck & Co. Inc. future price: according to them, 6MK price has a max estimate of 148.76 EUR and a min estimate of 95.98 EUR. Watch 6MK chart and read a more detailed Merck & Co. Inc. stock forecast: see what analysts think of Merck & Co. Inc. and suggest that you do with its stocks.
6MK reached its all-time high on Jun 25, 2024 with the price of 124.60 EUR, and its all-time low was 20.61 EUR and was reached on Aug 9, 2011. View more price dynamics on 6MK chart.
See other stocks reaching their highest and lowest prices.
6MK stock is 0.21% volatile and has beta coefficient of 0.61. Track Merck & Co. Inc. stock price on the chart and check out the list of the most volatile stocks — is Merck & Co. Inc. there?
Today Merck & Co. Inc. has the market capitalization of ‪244.02 B‬, it has increased by 4.34% over the last week.
Yes, you can track Merck & Co. Inc. financials in yearly and quarterly reports right on TradingView.
Merck & Co. Inc. is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
6MK earnings for the last quarter are 1.41 EUR per share, whereas the estimation was 1.33 EUR resulting in a 5.80% surprise. The estimated earnings for the next quarter are 1.76 EUR per share. See more details about Merck & Co. Inc. earnings.
Merck & Co. Inc. revenue for the last quarter amounts to ‪14.96 B‬ EUR, despite the estimated figure of ‪14.80 B‬ EUR. In the next quarter, revenue is expected to reach ‪14.81 B‬ EUR.
6MK net income for the last quarter is ‪2.84 B‬ EUR, while the quarter before that showed ‪5.09 B‬ EUR of net income which accounts for −44.32% change. Track more Merck & Co. Inc. financial stats to get the full picture.
Yes, 6MK dividends are paid quarterly. The last dividend per share was 0.69 EUR. As of today, Dividend Yield (TTM)% is 3.04%. Tracking Merck & Co. Inc. dividends might help you take more informed decisions.
Merck & Co. Inc. dividend yield was 2.72% in 2023, and payout ratio reached ‪2.07 K‬%. The year before the numbers were 2.52% and 49.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 27, 2024, the company has ‪72.00 K‬ employees. See our rating of the largest employees — is Merck & Co. Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck & Co. Inc. EBITDA is ‪16.76 B‬ EUR, and current EBITDA margin is 11.45%. See more stats in Merck & Co. Inc. financial statements.
Like other stocks, 6MK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck & Co. Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck & Co. Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck & Co. Inc. stock shows the sell signal. See more of Merck & Co. Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.